CN102180909A - Iridium complex phosphor material taking phthalazine derivative as ligand and preparation method thereof - Google Patents

Iridium complex phosphor material taking phthalazine derivative as ligand and preparation method thereof Download PDF

Info

Publication number
CN102180909A
CN102180909A CN201110068854XA CN201110068854A CN102180909A CN 102180909 A CN102180909 A CN 102180909A CN 201110068854X A CN201110068854X A CN 201110068854XA CN 201110068854 A CN201110068854 A CN 201110068854A CN 102180909 A CN102180909 A CN 102180909A
Authority
CN
China
Prior art keywords
aryl
formula
iridium
compound
organic solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201110068854XA
Other languages
Chinese (zh)
Other versions
CN102180909B (en
Inventor
梅群波
王玲霞
黄维
童碧海
郭远辉
翁洁娜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Post and Telecommunication University
Nanjing University of Posts and Telecommunications
Original Assignee
Nanjing Post and Telecommunication University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Post and Telecommunication University filed Critical Nanjing Post and Telecommunication University
Priority to CN201110068854.XA priority Critical patent/CN102180909B/en
Publication of CN102180909A publication Critical patent/CN102180909A/en
Application granted granted Critical
Publication of CN102180909B publication Critical patent/CN102180909B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention discloses an iridium complex phosphor material taking a phthalazine derivative as a ligand. The structure of the material is shown as formulas (I) and (II), wherein Ar represents aryl, substituted aryl, heterocycle aryl and substituted heterocycle aryl; R can be one of a halogen atom, alkyl, substituted alkyl, alkoxyl, aryloxy, an alkylthio group, arylthio, aromatic amino, aliphatic amino or a heterocyclic substituent; L^Y can be one of N-COOH, 8-hydroxyquinoline, beta-diketone, N^NH and the like; N^N can be bipyridyl, diquinoline, 1,10-phenanthroline, a derivative of the 1,10-phenanthroline and the like; and Z can be hexafluorophosphate and perchlorate. A dicyclic or ionic iridium complex phosphorescent electroluminescent device taking the phthalazine derivative as the ligand obtained with the preparation method has high internal and external quantum yields, high luminance and high stability. A dicyclic iridium complex is shown as a formula (I), i.e., (C^N)2Ir(L^Y); and an ionic iridium complex is shown as a formula (II), i.e., (C^N)2Ir(N^N)<+>Z<->.

Description

It with the phthalazine derivatives iridium complex phosphorescence material of part and preparation method thereof
Technical field
The present invention relates to a class luminescent material, relating to a class specifically is iridium complex phosphorescence material of part and preparation method thereof with the phthalazine derivatives
Background technology
Organic electroluminescence device has that driving voltage is low, response speed is fast, angular field of view is wide and can change luminescent properties by the chemical structure fine setting make rich color, realize easily advantages such as resolving power height, in light weight, large-area flat-plate demonstration, be described as " 21 century flat panel display ", become the focus of subjects such as material, information, physics and flat pannel display area research.Wherein, active in present organic electroluminescent research based on the electroluminescent phosphorescence luminescent material of heavy metal complex.Has d 6And d 8The heavy metal atom of electronic structure such as platinum (Pt), iridium (Ir), osmium (Os) etc., because their intensive spin orbitals coupling, make the singlet exciton and the triplet excitons of its title complex mix, triplet state has some singlet feature on the one hand, the symmetry of triplet excitons is destroyed, thereby shortening phosphorescent lifetime, make original triplet state increase the character of some singlet state, increased the intersystem crossing ability, the triplet excited state that causes prohibiting becomes the part permission to ground state transition, phosphorescence can be launched smoothly, improved luminous efficiency, internal quantum efficiency can reach 100%.
The higher phosphorescent substance of luminous efficiency is a metal iridium complex at present, and strong light emission is promptly arranged under the room temperature, illustrates that it has stronger spin orbit coupling effect.The characteristics of this class title complex are: luminous from metal to the energy of part shift (metal-to-ligand charge transfer, MLCT) or part π → π *Transition of electron, phosphorescent lifetime is generally 1-14 μ s, being applied to device also has very high luminous efficiency.These characteristics make becomes the research focus of present electromechanical phosphorescent material to the research of complex of iridium.
When adopting phosphor material to prepare electroluminescent device as luminescence center, because it has long lifetime of excited state, when excited triplet state concentration is higher, take place easily to bury in oblivion between triplet state-triplet state and triplet state-polaron between bury in oblivion, reduce the luminous efficiency of device.For avoiding the generation of this phenomenon, can with the phosphor material object, mix in the material of main part.Usually mix less than 10% phosphorescence guest materials in the luminescent layer of phosphorescence device and occupy in 90% the host compound, the main body proportion is very large, and carrier transport is mainly born by main body.In guest materials, introduce groups such as phenyl, carbazyl, three arylamine, also can effectively improve doping content, improve carrier mobility speed, and then improve device performance.
The transition metal organic coordination compound belongs to the luminous luminescent material of part of acceptor center atom perturbation, and part plays a decisive role to its stability and photoelectric properties, therefore can obtain performance, the different phosphor material of glow color by ligand design with modification.
With the phthalazine derivatives is that ligand iridium complex is compared with the common complex of iridium that contains other C^N part, and the bond length of coordination N atom and Ir atom is shorter, and bond energy is bigger.It is easier to be synthetic and very high thermostability arranged to have the material of this structure, based on the electroluminescent device of this material is also arranged very long work-ing life.Simultaneously, the preparation cost of phthalazines luminescent material also is one of the problem that must consider of practicability.Usually when the part of synthetic complex of iridium, often need to use expensive catalysts, and severe reaction conditions, and this part preparation is simple, with low cost, it is convenient to purify, and is easy to introduce functional unit.
Summary of the invention
Technical problem: the objective of the invention is to develop and a kind ofly have advantages such as excellent photoelectric properties, stability, film-forming properties, solvability, and prepare easy, with low cost luminescent material.
Technical scheme: of the present invention is that the iridium complex phosphorescence material of part is the compound of following formula (I) or formula (II) general formula with the phthalazine derivatives:
Figure BSA00000456343900021
Dicyclo complex of iridium ionic type iridium complex
(C^N) 2Ir(L^Y) (C^N) 2Ir(N^N) +Z -
Formula (I) formula (II)
Wherein Ar represents aryl, substituted aryl, heterocyclic aryl and substituted heterocycle aryl, and R is a kind of in halogen atom, alkyl, substituted alkyl, alkoxyl group, aryloxy, alkylthio, arylthio, fragrant amido, fat amido or the heterocyclic substituent; L^Y is wherein a kind of of N-COOH class, oxine class, beta-diketon class, N^NH; N^N is dipyridyl, diquinolyl, 1, a kind of in 10-phenanthroline and the derivative thereof; Z is hexafluoro-phosphate radical or perchlorate.
In formula (I), formula (II) general formula, aryl or substituted aryl are a kind of in benzene, biphenyl, naphthalene, acenaphthene, anthracene, phenanthrene, Bi, perylene, fluorenes, the spiral shell fluorenes; Heterocyclic aryl or substituted heterocycle aryl are a kind of in pyrroles, pyridine, furans, thiophene, carbazole, silicon fluorenes, phosphorus fluorenes, quinoline, isoquinoline 99.9, phthalazines, pyrimidine, pyridazine, pyrazine, thiodiphenylamine, acridine, dihydroketoacridine, phenanthroline, indoles, thiazole, diazole, triazole, benzodiazole, the benzothiazole; The substituting group of aryl or heterocyclic aryl is a kind of in halogen, alkyl, alkoxyl group, amino, hydroxyl, sulfydryl, ester group, boric acid ester group, acyl group, amide group, cyano group, aryloxy, aromatic base or the heterocyclic substituent, and the number of substituted aryl or substituted heterocycle aryl is single or multiple.
The preparation method comprises following synthesis step:
Figure BSA00000456343900031
Formula (1) formula (2) formula (3) formula (4)
The compound of a.Ar representative is dissolved in non-polar organic solvent, in the presence of catalyzer, carries out friedel-crafts acylation reaction with Tetra hydro Phthalic anhydride under 20~80 ℃, and reaction 5h~2d obtains a class suc as formula (1) represented 2-carbonyl benzoic acid derivative;
B. 2-carbonyl benzoic acid derivative is dissolved in polar organic solvent, adds hydrazine, 20~100 ℃ are stirred 12h~5d down, obtain a class and replace phthalazines-4-ketone suc as formula (2) represented 1-;
C. 1-is replaced phthalazines-4-ketone and be dissolved in non-polar organic solvent, stir 4~48h down at 20~90 ℃, obtain a class suc as formula (3) represented 1-replacement-4-halo phthalazine compound with halide reagent;
D.1-replacement-4-halo phthalazine derivatives is dissolved in polar organic solvent, under catalyst, with the compound that contains active group by hydrocarbylation or Ullmann reaction obtain at last a class suc as formula (4) represented 1,4-two replaces phthalazine compounds;
E.IrCl 3Soluble in water, add 1,4-two replaces phthalazine compound and organic solvent, and temperature is controlled under 50~200 ℃, N 2Lucifuge stirs 8~48h in the protection, gets the dichloro endo compound of iridium;
F. the dichloro endo compound with iridium is dissolved in the organic solvent, in the effect of alkali, stirs 3~48h with assistant ligand (L^Y) down at 20~200 ℃, obtains the dicyclo metallized complex of iridium;
G. the dichloro endo compound with iridium is dissolved in the organic solvent, stirs 3~48h with corresponding assistant ligand (N^N) down at 20~200 ℃, and cooling adds salt, stirring at room, and obtaining with the phthalazine derivatives is ionic type iridium (III) title complex of part.
The reactant consumption of described step a is, by the mole umber, and 1 part of Tetra hydro Phthalic anhydride, 1~3 part of the compound of Ar representative, 10~20 parts of non-polar organic solvents, 1~5 part of catalyzer; Wherein the compound of Ar representative is aryl, substituted aryl, heterocyclic aryl or substituted heterocycle aryl, and described aryl or substituted aryl are benzene, biphenyl, naphthalene, acenaphthene, anthracene, phenanthrene, Bi, perylene, fluorenes or spiral shell fluorenes; Substituted heterocycle aryl or substituted heterocycle aryl are pyrroles, pyridine, furans, thiophene, carbazole, silicon fluorenes, phosphorus fluorenes, quinoline, isoquinoline 99.9, phthalazines, pyrimidine, pyridazine, pyrazine, thiodiphenylamine, acridine, dihydroketoacridine, phenanthroline, indoles, thiazole, diazole, triazole, benzodiazole or benzothiazole; Described non-polar organic solvent is a chloroform, 1, and 2-ethylene dichloride, dithiocarbonic anhydride, tetracol phenixin, methylene dichloride, the mixture of one or more in the oil of mirbane etc.; Described catalyzer is AlCl 3, ZnCl 2, BF 3, FeCl 3Or SbF 5
The reactant consumption of described step b is, by the mole umber, and 1 part in 2-carbonyl benzoic acid derivative, 1~50 part of hydrazine, 10~80 parts of polar organic solvents, described polar organic solvent are ethanol, N, dinethylformamide, tetrahydrofuran (THF), acetone, acetonitrile or dimethyl sulfoxide (DMSO).
The reactant consumption of described step c is, by the mole umber, 1-replaces 1 part of phthalazines-4-ketone, and 1~8 part of halide reagent, 10~50 parts of non-polar organic solvents, described halide reagent are haloid acid, halogenation sulfoxide, phosphorus pentahalides, phosphorus trihalide or three oxyhalogen phosphorus; X in the formula (3) is halogen atoms such as F, Cl, Br, I; Described non-polar organic solvent is a chloroform, 1,2 ethylene dichloride, dithiocarbonic anhydride, tetracol phenixin, methylene dichloride or oil of mirbane.
The reactant consumption of described steps d is, by the mole umber, 1 part of 1-replacement-4-halogen phthalazine compound, 1~5 part of the compound that contains active group, 1~3 part of catalyzer, 5~30 parts of polar organic solvents, the described compound that contains active group is alkyl, substituted alkyl, alcohol, phenol, amine, aromatic amine or heterogeneous ring compound; Described catalyzer is mineral alkali, organic bases, salt or metal species; Described mineral alkali is salt of wormwood, saleratus, yellow soda ash or sodium bicarbonate, and described organic bases is triethylamine or pyridine, and described salt is Cu (I) salt or Cu (II) salt.
The reactant consumption of described step e is, by mole umber, IrCl 31 part, 1,4-two replaces 2~5 parts of phthalazine compounds, and 50~300 parts of organic solvents, described organic solvent are ethoxy ethanol, glycidyl ether or glycerine.
The reactant consumption of described step f is, by the mole umber, and 1 part of the dichloro endo compound of iridium, 1~5 part of assistant ligand, 1~5 part in alkali, 10~500 parts of organic solvents, described organic solvent are one or more the mixtures in methylene dichloride, ethylene glycol ethyl ether, the glycerine; Described alkali is mineral alkali or organic bases; Described mineral alkali is salt of wormwood, saleratus, yellow soda ash or sodium bicarbonate; Described organic bases is triethylamine or pyridine.
The reactant consumption of described step g is, by the mole umber, 1 part of the dichloro endo compound of iridium, 1~5 part of assistant ligand, 10~500 parts of organic solvents, 1~5 part of salt, described organic solvent are methylene dichloride, chloroform, tetracol phenixin, 1, the mixture of one or more in 2-ethylene dichloride, ethylene glycol ethyl ether, glycerine, ethanol, the methyl alcohol; Described salt is Potassium Hexafluorophosphate, ammonium hexafluorophosphate, lithium hexafluoro phosphate, sodium hexafluoro phosphate, phosphofluoric acid silver, phosphofluoric acid barium, phosphofluoric acid calcium, phosphofluoric acid magnesium, ammoniumper chlorate, potassium perchlorate, magnesium perchlorate, lithium perchlorate or sodium perchlorate.
Beneficial effect: phosphorescent iridium complex of the present invention, at first 1-is replaced phthalazines-4-ketone through halogenation treatment, improve the heterocyclic conjugated degree, and replace halogen atom with the compound that contains active group, further improve solvability, cavity transmission ability, thermostability and the film-forming properties of title complex, the introducing of these groups can produce certain steric effect in addition, thereby reduces the direct effect between the title complex luminescence center, reduce the self-quenching phenomenon of triplet exciton, improve the luminescent properties of material.The electroluminescent device that adopts this phosphorescent iridium complex to make has very high inside and outside quantum yield, luminosity and stability.
Obtained the dicyclo complex of iridium and the ionic type iridium complex of phthalazines iridium among the present invention, complex structure has been characterized by nucleus magnetic resonance, mass spectrum, infrared spectra, single crystal diffraction etc.Utilize the optical physics performance of methods such as ultraviolet, fluorescence spectrum, single photon counting method, cyclic voltammetry to them then, character such as orbital energy level are studied.The present invention has studied the luminescent properties of this micromolecular metal iridium complex and has introduced the influence of different function units to this title complex glow color and luminous efficiency.
Advantages such as complex of iridium of the present invention has good stability, solvability is good, luminous efficiency is high, synthesis technique is simple, with low cost are a kind of ruddiness phosphor materials of superior performance.
Description of drawings
Fig. 1. among the embodiment 1, ECzPQCz and (ECzPQCz) 2The uv-absorbing of Ir (Pic) in methylene dichloride and (ECzPQCz) 2The fluorescence emission spectrum of Ir (Pic).
Fig. 2. among the embodiment 3, TPAPQCz and (TPAPQCz) 2The uv-absorbing of Ir (Pic) in methylene dichloride and (TPAPQCz) 2The fluorescence emission spectrum of Ir (Pic).
Fig. 3. among the embodiment 4, TPAPQPz and (TPAPQPz) 2The uv-absorbing of Ir (Pic) in methylene dichloride and (TPAPQPz) 2The fluorescence emission spectrum of Ir (Pic).
Embodiment
Phosphorescent iridium complex of the present invention is to form dicyclo metal iridium complex (C^N) with phthalazine derivatives and metal iridium (III) coordination 2Ir (L^Y) or ionic title complex (C^N) 2Ir (N^N) +Z -, its structure can be represented by formula (I) or formula (II):
Figure BSA00000456343900051
Dicyclo complex of iridium ionic type iridium complex
(C^N) 2Ir(L^Y) (C^N) 2Ir(N^N) +Z -
Formula (I) formula (II)
Wherein R can be a kind of in halogen atom, alkyl, substituted alkyl, alkoxyl group, aryloxy, alkylthio, arylthio, fragrant amido, fat amido or the heterocyclic substituent; Ar represents aryl, substituted aryl, heterocyclic aryl and substituted heterocycle aryl.Aryl or substituted aryl can be aromatic compounds such as benzene, biphenyl, naphthalene, acenaphthene, anthracene, phenanthrene, Bi, perylene, fluorenes, spiral shell fluorenes and contain its substituent derivative.Heterocyclic aryl or substituted heterocycle aryl can be heterocyclic aromatic compounds such as pyrroles, pyridine, furans, thiophene, carbazole, silicon fluorenes, phosphorus fluorenes, quinoline, isoquinoline 99.9, phthalazines, pyrimidine, pyridazine, pyrazine, thiodiphenylamine, acridine, dihydroketoacridine, phenanthroline, indoles, thiazole, diazole, triazole, benzodiazole, benzothiazole and contain substituent derivative.The substituting group of aryl or heterocyclic aryl can be halogen, alkyl, alkoxyl group, amino, hydroxyl, sulfydryl, ester group, boric acid ester group, acyl group, amide group, cyano group, aryloxy, aromatic base or heterocyclic substituent etc.The substituent number of aryl or heterocyclic aryl can be for single or multiple.L^Y can be wherein a kind of such as N-COOH class, oxine class, beta-diketon class, N^NH; N^N can be dipyridyl, diquinolyl, 1,10-phenanthroline and derivative thereof etc.; Z can be hexafluoro-phosphate radical, perchlorate etc.
The preparation method of phosphorescent iridium complex of the present invention is characterized in that comprising the steps:
Figure BSA00000456343900061
Formula (1) formula (2) formula (3) formula (4)
(1) compound of Ar representative is dissolved in non-polar organic solvent, in the presence of catalyzer, carries out friedel-crafts acylation reaction with Tetra hydro Phthalic anhydride under 20~80 ℃, and reaction 5h~2d obtains a class suc as formula (1) represented 2-carbonyl benzoic acid derivative;
(2) 2-carbonyl benzoic acid derivative is dissolved in polar organic solvent, adds hydrazine, 20~100 ℃ are stirred 12h~5d down, obtain a class and replace phthalazines-4-ketone suc as formula (2) represented 1-;
(3) 1-is replaced phthalazines-4-ketone and be dissolved in non-polar organic solvent, stir 4~48h down at 20~90 ℃, obtain a class suc as formula (3) represented 1-replacement-4-halo phthalazine compound with halide reagent;
(4) 1-replacement-4-halo phthalazine derivatives is dissolved in polar organic solvent, under catalyst, with the compound that contains active group by hydrocarbylation or Ullmann reaction obtain at last a class suc as formula (4) represented 1,4-two replaces phthalazine compounds;
(5) IrCl 3Soluble in water, add 1,4-two replaces phthalazine compound and organic solvent, and temperature is controlled under 50~200 ℃, N 2Lucifuge stirs 8~48h in the protection, gets the dichloro endo compound of iridium;
(6) preparation of dicyclo metallized complex of iridium: the dichloro endo compound of iridium is dissolved in the organic solvent,, stirs 3~48h down at 20~200 ℃, obtain the dicyclo metal iridium complex with assistant ligand (L^Y) in the effect of alkali;
(7) preparation of ionic type iridium complex: the dichloro endo compound of iridium is dissolved in the organic solvent, stirs 3~48h with corresponding assistant ligand (N^N) down at 20~200 ℃, cooling adds salt, and stirring at room obtains ionic type iridium (III) title complex.
Figure BSA00000456343900063
The preparation method's of phthalazines complex of iridium optimum condition is:
The reactant consumption of step (1) is, by the mole umber, 1 part of Tetra hydro Phthalic anhydride, 1~3 part of aryl or heterocyclic aryl, 10~20 parts of non-polar organic solvents, 1~5 part of Lewis acid, wherein the compound of Ar representative can be an aryl, replace aryl, heterocyclic aryl and substituted heterocycle aryl, described aryl or substituted aryl can be benzene, biphenyl, naphthalene, acenaphthene, anthracene, luxuriant and rich with fragrance, pyrene perylene, fluorenes, aromatic compounds such as spiral shell fluorenes and contain its substituent derivative, heterocyclic aryl or substituted heterocycle aryl can be the pyrroles, pyridine, furans, thiophene, carbazole, the silicon fluorenes, the phosphorus fluorenes, quinoline, isoquinoline 99.9, phthalazines, pyrimidine, pyridazine, pyrazine, thiodiphenylamine, acridine, dihydroketoacridine, phenanthroline, indoles, thiazole, diazole, triazole, benzodiazole, heteroaromaticizations such as benzothiazole; Described non-polar organic solvent can be a chloroform, 1, and 2-ethylene dichloride, dithiocarbonic anhydride, tetracol phenixin, methylene dichloride, the mixture of one or more in the oil of mirbane etc.; Described Lewis acid can be AlCl 3, ZnCl 2, BF 3, FeCl 3, SbF 5Deng.
The reactant consumption of step (2) is, by the mole umber, and 1 part in 2-carbonyl benzoic acid derivative, 1~50 part of hydrazine, 10~80 parts of polar organic solvents, described polar organic solvent can be ethanol, N, dinethylformamide, tetrahydrofuran (THF), acetone, acetonitrile or dimethyl sulfoxide (DMSO) etc.
The reactant consumption of step (3) is, by the mole umber, 1-replaces 1 part of phthalazines-4-ketone, 1~8 part of halide reagent, 10~50 parts of non-polar organic solvents, described halide reagent can be haloid acid, halogenation sulfoxide, phosphorus pentahalides, phosphorus trihalide, three oxyhalogen phosphorus etc.; X in the formula (3) is halogen atoms such as F, Cl, Br, I; Described non-polar organic solvent can be a chloroform, 1,2 ethylene dichloride, dithiocarbonic anhydride, tetracol phenixin, methylene dichloride, oil of mirbane etc.
The reactant consumption of step (4) is, by the mole umber, 1 part of 1-replacement-4-halogen phthalazine compound, 1~5 part of the compound that contains active group, 1~3 part of catalyzer, 5~30 parts of polar organic solvents, the described compound that contains active group can be alkyl, substituted alkyl, alcohol, phenol, amine, aromatic amine, heterogeneous ring compound etc.; Described catalyzer is mineral alkali, organic bases, salt or metal species etc., described mineral alkali can be salt of wormwood, saleratus, yellow soda ash, sodium bicarbonate etc., described organic bases can be triethylamine, pyridine etc., and described salt can be Cu (I) salt, Cu (II) salt etc.
The reactant consumption of step (5) is, by mole umber, IrCl 31 part, 1,4-two replaces 2~5 parts of phthalazine compounds, and 50~300 parts of organic solvents, described organic solvent are ethoxy ethanol, glycidyl ether, glycerine etc.
The reactant consumption of step (6) is, by the mole umber, and 1 part of the dichloro endo compound of iridium, 1~5 part of assistant ligand, 1~5 part in alkali, 10~500 parts of organic solvents, described organic solvent can be one or more mixtures wherein such as methylene dichloride, ethylene glycol ethyl ether, glycerine; Described alkali can be mineral alkali and organic bases; Described mineral alkali can be salt of wormwood, saleratus, yellow soda ash, sodium bicarbonate etc.; Described organic bases can be triethylamine, pyridine etc.
The reactant consumption of step (7) is, by the mole umber, 1 part of the dichloro endo compound of iridium, 1~5 part of assistant ligand, 10~500 parts of organic solvents, 1~5 part of salt, described organic solvent can be methylene dichloride, chloroform, tetracol phenixin, 1, one or more mixture wherein such as 2-ethylene dichloride, ethylene glycol ethyl ether, glycerine, ethanol, methyl alcohol; Described salt can be Potassium Hexafluorophosphate, ammonium hexafluorophosphate, lithium hexafluoro phosphate, sodium hexafluoro phosphate, phosphofluoric acid silver, phosphofluoric acid barium, phosphofluoric acid calcium, phosphofluoric acid magnesium etc., ammoniumper chlorate, potassium perchlorate, magnesium perchlorate, lithium perchlorate, sodium perchlorate etc.
Following examples are to further specify of the present invention, are not limitations of the present invention.
Embodiment 1:
Take by weighing 2.78g (21mmol) AlCl 3, 2.31g (15.6mmol) Tetra hydro Phthalic anhydride adds the stirring of 10ml (156mmol) methylene dichloride ice bath and makes its dissolving in two-mouth bottle.Take by weighing 3.56g (18mmol) N-ethyl-9H-carbazole in the single port bottle, add 10ml (156mmol) methylene dichloride stirring at room, slowly drip above-mentioned mixed solution, continue stirred overnight at room temperature with separating funnel.Reaction finishes, and adds rare HCl and transfer to slightly acidic in reaction solution, adds suitable quantity of water, chloroform extraction, and the organic phase washing merges organic phase, anhydrous MgSO 4Drying is crossed column purification and is got 2-(9-ethyl-9H-carbazole-3-carbonyl) phenylformic acid.
Add 1.01g (2.9mmol) 2-(ethyl carbazole formyl)-phenylformic acid in the two-mouth bottle, N 2Hydrazine hydrate and 10ml (171mmol) ethanol of 5ml (129mmol) 80%, reflux 12h are injected in protection down.Reaction finishes, and is cooled to room temperature, and the adularescent precipitation is separated out, and filters washing with alcohol, dry 4-(9-ethyl-9H-carbazole-3-yl) phthalazines-1 (2H)-ketone that gets.
Add 2.0g (5.9mmol) 4-(N-ethyl) carbazole-1-phthalazone in the two-mouth bottle, N 2Protection adds 20ml (250mmo) CHCl down 3And 3ml (32.7mmol) POCl 3Be warming up to 60 ℃ of reaction 12h.Reaction finishes, and reaction solution is poured in the 400g water, and weak ammonia transfers PH to weakly alkaline, has solid to separate out, and filters, and the acetic acid ethyl dissolution solid is crossed column purification and got 3-(4-chlorine phthalazines-1-yl)-9-ethyl-9H-carbazole.
Take by weighing NaH and the two-mouth bottle of 1.00g (6mmol) carbazole and 0.31g (7mmol) 65%, N 2The anhydrous N of 5ml (65mmol), dinethylformamide, stirring at room 1h are injected in protection down; 1.79g (5mmol) 3-(4-chlorine phthalazines-1-yl)-9-ethyl-9H-carbazole is dissolved in 5ml (65mmol) N; in the dinethylformamide, slowly splash into reaction flask, continue stirred overnight at room temperature.Reaction solution is poured in the big water gaging, and ethyl acetate extraction is crossed column purification and is got 3-(4-(9H-carbazole-9-yl) phthalazines-1-yl)-9-ethyl-9H-carbazole.
Take by weighing 0.146g (0.3mmol) 3-(4-(9H-carbazole-9-yl) phthalazines-1-yl)-9-ethyl-9H-carbazole and 0.035g (0.1mmol) IrCl 3H 2O injects 1ml (55mmol) water and 3ml (31mmol) ethylene glycol ethyl ether, N in two-mouth bottle 2Be warming up to 80 ℃ of reaction 24h under the protection, be cooled to room temperature, filter, difference water, washing with alcohol solid, the dry dichloro endo compound that gets iridium.
The dichloro endo compound that takes by weighing 0.1g (0.042mmol) iridium is dissolved in 5ml (78mmol) methylene dichloride, add 0.015g (0.126mmol) pyridine carboxylic acid and 0.017g (0.126mmol) salt of wormwood, be warming up to 60 ℃ and stir 12h, cooling is crossed column purification and is got complex of iridium (ECzPQCz) 2Ir (Pic).
Embodiment 2:
Take by weighing NaH and the two-mouth bottle of 1.01g (6mmol) pentanoic and 0.31g (7mmol) 65%, N 2The anhydrous N of 5ml (65mmol), dinethylformamide, stirring at room 1h are injected in protection down; 1.79g (5mmol) 3-(4-chlorine phthalazines-1-yl)-9-ethyl-9H-carbazole is dissolved in 5ml (65mmol) N; in the dinethylformamide, slowly splash into reaction flask, continue stirred overnight at room temperature.Reaction solution is poured in the big water gaging, ethyl acetate extraction, dry organic phase concentrates, and crosses column purification and gets 4-(9-ethyl-9H-carbazole-3-yl)-N, N-phenylbenzene phthalazines-1-amine.
Take by weighing 0.147g (0.3mmol) 4-(9-ethyl-9H-carbazole-3-yl)-N, N-phenylbenzene phthalazines-1-amine and 0.035g (0.1mmol) IrCl 3H 2O injects 1ml (55mmol) water and 3ml (31mmol) ethylene glycol ethyl ether, N in two-mouth bottle 2Be warming up to 80 ℃ of reaction 24h under the protection, be cooled to room temperature, filter, difference water, washing with alcohol solid, the dry dichloro endo compound that gets iridium.
The dichloro endo compound that takes by weighing 0.101g (0.042mmol) iridium is dissolved in 5ml (78mmol) methylene dichloride, add 0.015g (0.126mmol) methyl ethyl diketone sodium salt and 0.017g (0.126mmol) salt of wormwood, be warming up to 60 ℃ and stir 12h, cooling is crossed column purification and is got complex of iridium (ECzPQDPA) 2Ir (acac).
Figure BSA00000456343900092
Embodiment 3:
Take by weighing 1.94g (14.5mmol) AlCl 3, 0.61g (4.12mmol) Tetra hydro Phthalic anhydride adds 15ml (234mmol) CH in two-mouth bottle 2Cl 2Ice bath stirs and makes its dissolving, stirs down to add 1.23g (5mmol) triphenylamine, continues stirred overnight at room temperature.Reaction finishes, and adds rare HCl and transfer to slightly acidic in reaction solution, and chloroform extraction merges organic phase, anhydrous MgSO 4Drying is crossed column purification and is got 2-(4-(diphenyl amino) benzoyl) phenylformic acid.
Add 1.14g (2.9mmol) 2-(4-(diphenyl amino) benzoyl) phenylformic acid in the two-mouth bottle, N 2Hydrazine hydrate and 10ml (171mmol) ethanol of an amount of 5ml (129mmol) 80%, reflux 12h are injected in protection down.Reaction finishes, and is cooled to room temperature, has yellow mercury oxide to separate out, and filters washing with alcohol, dry 4-(4-(diphenyl amino) phenyl) phthalazines-1 (2H)-ketone that gets.
Take by weighing 5.13g (13mmol) 4-(4-(diphenyl amino) phenyl) phthalazines-1 (2H)-ketone in two-mouth bottle, N 215ml (187mmol) CHCl is injected in protection down 3And 3ml (33mmol) POCl 3, be warming up to 60 ℃ and stir 8h, be cooled to room temperature, decompression steams CHCl 3, residuum to be poured in the water, weak ammonia is adjusted to weakly alkaline, has solid to produce, and crosses column purification and gets 4-(4-chlorine phthalazines-1-yl)-N, N-phenylbenzene aniline.
Take by weighing NaH and the two-mouth bottle of 1.17g (7mmol) carbazole and 0.32g (8mmol) 65%, N 2The anhydrous N of 5ml (65mmol), dinethylformamide, stirring at room 1h are injected in protection down; with 2.04g (5mmol) 4-(4-chlorine phthalazines-1-yl)-N, N-phenylbenzene aniline is dissolved in the anhydrous N of 5ml (65mmol), in the dinethylformamide; slowly splash into reaction flask, dropwise, stirred overnight at room temperature.Reaction solution is poured in the big water gaging, ethyl acetate extraction, dry organic phase is crossed column purification and is got 4-(4-(9H-carbazole-9-yl) phthalazines-1-yl)-N, N-phenylbenzene aniline.
Take by weighing 0.164g (0.3mmol) 4-(4-(9H-carbazole-9-yl) phthalazines-1-yl)-N, N-phenylbenzene aniline and 0.035g (0.1mmol) IrCl 3H 2O injects 1ml (55mmol) water and 3ml (31mmol) 7 glycol ethers, N in two-mouth bottle 2Be warming up to 80 ℃ of reaction 24h under the protection, be cooled to room temperature, filter, difference water, washing with alcohol solid, the dry dichloro endo compound that gets iridium.
The dichloro endo compound 0.109g (0.042mmol) of the above-mentioned iridium of exsiccant is dissolved in 5ml (78mmol) methylene dichloride, add 0.015g (0.126mmol) pyridine carboxylic acid and 0.017g (0.126mmol) salt of wormwood, be warming up to 50 ℃ and stir 12h, cooling, concentrate, cross column purification and get (TPAPQCz) 2Ir (Pic).
Figure BSA00000456343900101
Embodiment 4:
Take by weighing NaH and the two-mouth bottle of 1.39g (7mmol) thiodiphenylamine and 0.32g (8mmol) 65%, N 2The anhydrous N of 5ml (65mmol), dinethylformamide, stirring at room 1h are injected in protection down; with 2.04g (5mmol) 4-(4-chlorine phthalazines-1-yl)-N, N-phenylbenzene aniline is dissolved in the anhydrous N of 5ml (65mmol), in the dinethylformamide; slowly splash into reaction flask, dropwise, stirred overnight at room temperature.Reaction solution is poured in the big water gaging, ethyl acetate extraction, dry organic phase is crossed column purification and is got 4-(4-(10H-benzothiazine-10-yl) phthalazines-1-yl)-N, N-phenylbenzene aniline.
Take by weighing 0.171g (0.3mmol) 4-(4-(10H-benzothiazine-10-yl) phthalazines-1-yl)-N, N-phenylbenzene aniline and 0.035g (0.1mmol) IrCl 3H 2O injects 1ml (55mmol) water and 3ml (31mmol) ethylene glycol ethyl ether, N in two-mouth bottle 2Be warming up to 80 ℃ of reaction 24h under the protection, be cooled to room temperature, filter, difference water, washing with alcohol solid, the dry dichloro endo compound that gets iridium.
The dichloro endo compound 0.114g (0.042mmol) of the above-mentioned iridium of exsiccant is dissolved in 5ml (78mmol) methylene dichloride, add 0.015g (0.126mmol) pyridine carboxylic acid and 0.017g (0.126mmol) salt of wormwood, be warming up to 50 ℃ and stir 12h, cooling, concentrate, cross column purification and get (TPAPQPz) 2Ir (Pic).
Embodiment 5:
0.114g (0.042mmol) dichloro endo compound is dissolved in 5ml (63mmol) 1, in 2-ethylene dichloride and 3ml (51mmol) ethanol mixed solvent, add 0.08g (0.28mmol) 1, the 10-phenanthroline, being warming up to refluxes stirs 8h, reaction is cooled to room temperature after finishing, and adds 0046g (0.28mmol) ammonium hexafluorophosphate, stirring at room 2h, steam solvent, solid is dissolved in methylene dichloride, and the mistake column purification obtains the iridium that negatively charged ion is a hexafluoro-phosphate radical (III), and title complex [(TPAPQPz) 2Ir (N^N)] +(PF 6) -
Figure BSA00000456343900112

Claims (10)

1. one kind is the iridium complex phosphorescence material of part with the phthalazine derivatives, it is characterized in that this material is the compound of following formula (I) or formula (II) general formula:
Figure FSA00000456343800011
Dicyclo complex of iridium ionic type iridium complex
(C^N) 2Ir(L^Y) (C^N) 2Ir(N^N) +Z -
Formula (I) formula (II)
Wherein Ar represents aryl, substituted aryl, heterocyclic aryl and substituted heterocycle aryl, and R is a kind of in halogen atom, alkyl, substituted alkyl, alkoxyl group, aryloxy, alkylthio, arylthio, fragrant amido, fat amido or the heterocyclic substituent; L^Y is wherein a kind of of N-COOH class, oxine class, beta-diketon class, N^NH; N^N is dipyridyl, diquinolyl, 1, a kind of in 10-phenanthroline and the derivative thereof; Z is hexafluoro-phosphate radical or perchlorate.
2. according to claim 1 is the iridium complex phosphorescence material of part with the phthalazine derivatives, it is characterized in that in formula (I), formula (II) general formula aryl or substituted aryl are a kind of in benzene, biphenyl, naphthalene, acenaphthene, anthracene, phenanthrene, Bi, perylene, fluorenes, the spiral shell fluorenes; Heterocyclic aryl or substituted heterocycle aryl are a kind of in pyrroles, pyridine, furans, thiophene, carbazole, silicon fluorenes, phosphorus fluorenes, quinoline, isoquinoline 99.9, phthalazines, pyrimidine, pyridazine, pyrazine, thiodiphenylamine, acridine, dihydroketoacridine, phenanthroline, indoles, thiazole, diazole, triazole, benzodiazole, the benzothiazole; The substituting group of aryl or heterocyclic aryl is a kind of in halogen, alkyl, alkoxyl group, amino, hydroxyl, sulfydryl, ester group, boric acid ester group, acyl group, amide group, cyano group, aryloxy, aromatic base or the heterocyclic substituent, and the number of substituted aryl or substituted heterocycle aryl is single or multiple.
One kind as claimed in claim 1 be the iridium complex phosphorescence preparation methods of part with the phthalazine derivatives, it is characterized in that the preparation method comprises following synthesis step:
Figure FSA00000456343800012
Formula (1) formula (2) formula (3) formula (4)
The compound of a.Ar representative is dissolved in non-polar organic solvent, in the presence of catalyzer, carries out friedel-crafts acylation reaction with Tetra hydro Phthalic anhydride under 20~80 ℃, and reaction 5h~2d obtains a class suc as formula (1) represented 2-carbonyl benzoic acid derivative;
B. 2-carbonyl benzoic acid derivative is dissolved in polar organic solvent, adds hydrazine, 20~100 ℃ are stirred 12h~5d down, obtain a class and replace phthalazines-4-ketone suc as formula (2) represented 1-;
C. 1-is replaced phthalazines-4-ketone and be dissolved in non-polar organic solvent, stir 4~48h down at 20~90 ℃, obtain a class suc as formula (3) represented 1-replacement-4-halo phthalazine compound with halide reagent;
D.1-replacement-4-halo phthalazine derivatives is dissolved in polar organic solvent, under catalyst, with the compound that contains active group by hydrocarbylation or Ullmann reaction obtain at last a class suc as formula (4) represented 1,4-two replaces phthalazine compounds;
E.IrCl 3Soluble in water, add 1,4-two replaces phthalazine compound and organic solvent, and temperature is controlled under 50~200 ℃, N 2Lucifuge stirs 8~48h in the protection, gets the dichloro endo compound of iridium;
F. the dichloro endo compound with iridium is dissolved in the organic solvent, in the effect of alkali, stirs 3~48h with assistant ligand (L^Y) down at 20~200 ℃, obtains the dicyclo metallized complex of iridium;
G. the dichloro endo compound with iridium is dissolved in the organic solvent, stirs 3~48h with corresponding assistant ligand (N^N) down at 20~200 ℃, and cooling adds salt, stirring at room, and obtaining with the phthalazine derivatives is ionic type iridium (III) title complex of part.
4. according to claim 3 is the iridium complex phosphorescence preparation methods of part with the phthalazine derivatives, the reactant consumption that it is characterized in that described step a is, by the mole umber, 1 part of Tetra hydro Phthalic anhydride, 1~3 part of the compound of Ar representative, 10~20 parts of non-polar organic solvents, 1~5 part of catalyzer; Wherein the compound of Ar representative is aryl, substituted aryl, heterocyclic aryl or substituted heterocycle aryl, and described aryl or substituted aryl are benzene, biphenyl, naphthalene, acenaphthene, anthracene, phenanthrene, Bi, perylene, fluorenes or spiral shell fluorenes; Substituted heterocycle aryl or substituted heterocycle aryl are pyrroles, pyridine, furans, thiophene, carbazole, silicon fluorenes, phosphorus fluorenes, quinoline, isoquinoline 99.9, phthalazines, pyrimidine, pyridazine, pyrazine, thiodiphenylamine, acridine, dihydroketoacridine, phenanthroline, indoles, thiazole, diazole, triazole, benzodiazole or benzothiazole; Described non-polar organic solvent is a chloroform, 1, and 2-ethylene dichloride, dithiocarbonic anhydride, tetracol phenixin, methylene dichloride, the mixture of one or more in the oil of mirbane etc.; Described catalyzer is AlCl 3, ZnCl 2, BF 3, FeCl 3Or SbF 5
5. according to claim 3 is the iridium complex phosphorescence preparation methods of part with the phthalazine derivatives, the reactant consumption that it is characterized in that described step b is, by the mole umber, 1 part in 2-carbonyl benzoic acid derivative, 1~50 part of hydrazine, 10~80 parts of polar organic solvents, described polar organic solvent are ethanol, N, dinethylformamide, tetrahydrofuran (THF), acetone, acetonitrile or dimethyl sulfoxide (DMSO).
6. according to claim 3 is the iridium complex phosphorescence preparation methods of part with the phthalazine derivatives, the reactant consumption that it is characterized in that described step c is, by the mole umber, 1-replaces 1 part of phthalazines-4-ketone, 1~8 part of halide reagent, 10~50 parts of non-polar organic solvents, described halide reagent are haloid acid, halogenation sulfoxide, phosphorus pentahalides, phosphorus trihalide or three oxyhalogen phosphorus; X in the formula (3) is halogen atoms such as F, Cl, Br, I; Described non-polar organic solvent is a chloroform, 1,2 ethylene dichloride, dithiocarbonic anhydride, tetracol phenixin, methylene dichloride or oil of mirbane.
7. according to claim 3 is the iridium complex phosphorescence preparation methods of part with the phthalazine derivatives, the reactant consumption that it is characterized in that described steps d is, by the mole umber, 1 part of 1-replacement-4-halogen phthalazine compound, 1~5 part of the compound that contains active group, 1~3 part of catalyzer, 5~30 parts of polar organic solvents, the described compound that contains active group is alkyl, substituted alkyl, alcohol, phenol, amine, aromatic amine or heterogeneous ring compound; Described catalyzer is mineral alkali, organic bases, salt or metal species; Described mineral alkali is salt of wormwood, saleratus, yellow soda ash or sodium bicarbonate, and described organic bases is triethylamine or pyridine, and described salt is Cu (I) salt or Cu (II) salt.
8. according to claim 3 is the iridium complex phosphorescence preparation methods of part with the phthalazine derivatives, it is characterized in that the reactant consumption of described step e is, by mole umber, IrCl 31 part, 1,4-two replaces 2~5 parts of phthalazine compounds, and 50~300 parts of organic solvents, described organic solvent are ethoxy ethanol, glycidyl ether or glycerine.
9. according to claim 3 is the iridium complex phosphorescence preparation methods of part with the phthalazine derivatives, the reactant consumption that it is characterized in that described step f is, by the mole umber, 1 part of the dichloro endo compound of iridium, 1~5 part of assistant ligand, 1~5 part in alkali, 10~500 parts of organic solvents, described organic solvent are one or more the mixtures in methylene dichloride, ethylene glycol ethyl ether, the glycerine; Described alkali is mineral alkali or organic bases; Described mineral alkali is carbonic acid clock, saleratus, yellow soda ash or sodium bicarbonate; Described organic bases is triethylamine or pyridine.
10. according to claim 3 is the iridium complex phosphorescence preparation methods of part with the phthalazine derivatives, the reactant consumption that it is characterized in that described step g is, by the mole umber, 1 part of the dichloro endo compound of iridium, 1~5 part of assistant ligand, 10~500 parts of organic solvents, 1~5 part of salt, described organic solvent is methylene dichloride, chloroform, tetracol phenixin, 1, the mixture of one or more in 2-ethylene dichloride, ethylene glycol ethyl ether, glycerine, ethanol, the methyl alcohol; Described salt is Potassium Hexafluorophosphate, ammonium hexafluorophosphate, lithium hexafluoro phosphate, sodium hexafluoro phosphate, phosphofluoric acid silver, phosphofluoric acid barium, phosphofluoric acid calcium, phosphofluoric acid magnesium, ammoniumper chlorate, potassium perchlorate, magnesium perchlorate, lithium perchlorate or sodium perchlorate.
CN201110068854.XA 2011-03-18 2011-03-18 Iridium complex phosphor material taking phthalazine derivative as ligand and preparation method thereof Expired - Fee Related CN102180909B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110068854.XA CN102180909B (en) 2011-03-18 2011-03-18 Iridium complex phosphor material taking phthalazine derivative as ligand and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110068854.XA CN102180909B (en) 2011-03-18 2011-03-18 Iridium complex phosphor material taking phthalazine derivative as ligand and preparation method thereof

Publications (2)

Publication Number Publication Date
CN102180909A true CN102180909A (en) 2011-09-14
CN102180909B CN102180909B (en) 2014-10-22

Family

ID=44567221

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110068854.XA Expired - Fee Related CN102180909B (en) 2011-03-18 2011-03-18 Iridium complex phosphor material taking phthalazine derivative as ligand and preparation method thereof

Country Status (1)

Country Link
CN (1) CN102180909B (en)

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102408450A (en) * 2011-09-23 2012-04-11 安徽工业大学 Preparation method of iridium complex-containing phosphorescence material and its application in cobalt ion detection
CN102660254A (en) * 2012-04-23 2012-09-12 安徽工业大学 Iridium complex-containing phosphorescent material, preparation method and application in mercury ion detection
CN102690235A (en) * 2012-05-25 2012-09-26 南京邮电大学 Iridium complex containing hole transporting functional group, and electroluminescent device of iridium complex
CN103172677A (en) * 2013-03-19 2013-06-26 西安交通大学 Organic metal iridium complex luminescent material and synthetic method of material
CN103289677A (en) * 2013-05-06 2013-09-11 南京邮电大学 Iridium complex phosphor material taking phthalazine derivative as ligand and preparation method thereof
CN103421047A (en) * 2013-07-31 2013-12-04 中科院广州化学有限公司 Iridium complex in response to Cu2<+>, and preparation method and application thereof
CN103965890A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965259A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965256A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965258A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965892A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965255A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light-emitting organic electrophosphorescent material iridium complex, its preparation method and organic electroluminescent device
CN103965888A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965257A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965879A (en) * 2013-01-30 2014-08-06 海洋王照明科技股份有限公司 Blue light-emitting organic electroluminescent material, its preparation method and organic electroluminescent device
CN103965260A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965889A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965891A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965263A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965262A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965252A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light-emitting organic electrophosphorescent material iridium complex, its preparation method and organic electroluminescent device
CN103965887A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light-emitting organic electrophosphorescent material iridium complex, its preparation method and organic electroluminescent device
CN103965261A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965254A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light-emitting organic electrophosphorescent material iridium complex, its preparation method and organic electroluminescent device
CN103965253A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light-emitting organic electrophosphorescent material iridium complex, its preparation method and organic electroluminescent device
CN104177416A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Phosphorescence material iridium metal complex, preparation method and organic electroluminescent device
CN104177435A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Red phosphorescence iridium complexes, preparing method thereof and organic electroluminescence device
CN104177431A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Phosphorescence iridium complexes, preparing method thereof and organic electroluminescent device
CN104178114A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Red phosphorescence iridium complexes, preparing method thereof and organic electroluminescence device
CN104177436A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Red phosphorescence iridium complexes, preparing method thereof and organic electroluminescence device
CN104178106A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Red phosphorescence iridium metal complex, preparation method and organic electroluminescent device
CN104177434A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Red phosphorescence iridium complexes, preparing method thereof and organic electroluminescence device
CN104177433A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Phosphorescence iridium complexes, preparing method thereof and organic electroluminescent device
US9221767B2 (en) 2013-01-18 2015-12-29 Bristol-Myers Squibb Company Substituted phthalazinones as rock inhibitors
CN105418356A (en) * 2014-08-11 2016-03-23 上海和辉光电有限公司 Organic iridium coordination compound and preparation method thereof, light emitting material containing organic iridium coordination compound, and organic electroluminescent device containing organic iridium coordination compound
US9902702B2 (en) 2014-07-15 2018-02-27 Bristol-Myers Squibb Company Spirocycloheptanes as inhibitors of rock
CN108084231A (en) * 2018-01-31 2018-05-29 安徽工业大学 A kind of material containing iridium complex phosphorescence and preparation and the application in beryllium ion detection
JP2021073220A (en) * 2014-02-14 2021-05-13 ユニバーサル ディスプレイ コーポレイション Organic electroluminescence material and device
CN115160378A (en) * 2021-07-20 2022-10-11 安徽工业大学 Red light organic electrophosphorescent material and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060261730A1 (en) * 2005-05-20 2006-11-23 City University Of Hong Kong Red-emitting electrophosphorescent devices
CN101200635A (en) * 2007-11-27 2008-06-18 中山大学 Phosphorescent iridium complex and organic electroluminescent device thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060261730A1 (en) * 2005-05-20 2006-11-23 City University Of Hong Kong Red-emitting electrophosphorescent devices
CN101200635A (en) * 2007-11-27 2008-06-18 中山大学 Phosphorescent iridium complex and organic electroluminescent device thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
SERGEY LAMANSKY等,: "Synthesis and characterization of phosphorescent cyclometalated iridium complexes", 《INORG. CHEM.》, vol. 40, no. 7, 1 March 2001 (2001-03-01) *
刘春: "基于Hg(II)识别的荧光化学传感与荧光成像的研究", 《内蒙古大学硕士学位论文》, 11 November 2009 (2009-11-11) *
张春林等,: "一种含咔唑基哒嗪的新型金属铱电致磷光材料的合成与性能研究", 《有机化学》, vol. 30, no. 9, 30 September 2010 (2010-09-30), pages 1354 - 1357 *
张秀菊等,: "以铱为内核的有机电致磷光材料", 《化学进展》, vol. 18, no. 78, 3 August 2006 (2006-08-03), pages 870 - 882 *

Cited By (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102408450B (en) * 2011-09-23 2014-12-31 安徽工业大学 Preparation method of iridium complex-containing phosphorescence material and its application in cobalt ion detection
CN102408450A (en) * 2011-09-23 2012-04-11 安徽工业大学 Preparation method of iridium complex-containing phosphorescence material and its application in cobalt ion detection
CN102660254A (en) * 2012-04-23 2012-09-12 安徽工业大学 Iridium complex-containing phosphorescent material, preparation method and application in mercury ion detection
CN102660254B (en) * 2012-04-23 2014-07-23 安徽工业大学 Iridium complex-containing phosphorescent material, preparation method and application in mercury ion detection
CN102690235A (en) * 2012-05-25 2012-09-26 南京邮电大学 Iridium complex containing hole transporting functional group, and electroluminescent device of iridium complex
US10385026B2 (en) 2013-01-18 2019-08-20 Bristol-Myers Squibb Company Phthalazinones and isoquinolinones as rock inhibitors
US9926282B2 (en) 2013-01-18 2018-03-27 Bristol-Myers Squibb Company Phthalazinones and isoquinolinones as rock inhibitors
US9221767B2 (en) 2013-01-18 2015-12-29 Bristol-Myers Squibb Company Substituted phthalazinones as rock inhibitors
CN103965879A (en) * 2013-01-30 2014-08-06 海洋王照明科技股份有限公司 Blue light-emitting organic electroluminescent material, its preparation method and organic electroluminescent device
CN103965887A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light-emitting organic electrophosphorescent material iridium complex, its preparation method and organic electroluminescent device
CN103965262A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965892A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965255A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light-emitting organic electrophosphorescent material iridium complex, its preparation method and organic electroluminescent device
CN103965888A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965257A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965256A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965260A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965889A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965891A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965263A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965890A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965252A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light-emitting organic electrophosphorescent material iridium complex, its preparation method and organic electroluminescent device
CN103965259A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965261A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103965254A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light-emitting organic electrophosphorescent material iridium complex, its preparation method and organic electroluminescent device
CN103965253A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light-emitting organic electrophosphorescent material iridium complex, its preparation method and organic electroluminescent device
CN103965258A (en) * 2013-01-31 2014-08-06 海洋王照明科技股份有限公司 Red light organic electrophosphorescence material metal iridium coordination compound and preparation method thereof, and organic electroluminescent device
CN103172677A (en) * 2013-03-19 2013-06-26 西安交通大学 Organic metal iridium complex luminescent material and synthetic method of material
CN103172677B (en) * 2013-03-19 2015-07-08 西安交通大学 Organic metal iridium complex luminescent material and synthetic method of material
CN103289677A (en) * 2013-05-06 2013-09-11 南京邮电大学 Iridium complex phosphor material taking phthalazine derivative as ligand and preparation method thereof
CN104177431A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Phosphorescence iridium complexes, preparing method thereof and organic electroluminescent device
CN104177416A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Phosphorescence material iridium metal complex, preparation method and organic electroluminescent device
CN104177434A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Red phosphorescence iridium complexes, preparing method thereof and organic electroluminescence device
CN104177433A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Phosphorescence iridium complexes, preparing method thereof and organic electroluminescent device
CN104177436A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Red phosphorescence iridium complexes, preparing method thereof and organic electroluminescence device
CN104178114A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Red phosphorescence iridium complexes, preparing method thereof and organic electroluminescence device
CN104178106A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Red phosphorescence iridium metal complex, preparation method and organic electroluminescent device
CN104177435A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Red phosphorescence iridium complexes, preparing method thereof and organic electroluminescence device
CN103421047A (en) * 2013-07-31 2013-12-04 中科院广州化学有限公司 Iridium complex in response to Cu2<+>, and preparation method and application thereof
CN103421047B (en) * 2013-07-31 2016-03-16 中科院广州化学有限公司 A kind of to Cu 2+what have response contains complex of iridium and preparation method thereof and application
JP2021073220A (en) * 2014-02-14 2021-05-13 ユニバーサル ディスプレイ コーポレイション Organic electroluminescence material and device
US9902702B2 (en) 2014-07-15 2018-02-27 Bristol-Myers Squibb Company Spirocycloheptanes as inhibitors of rock
CN105418356A (en) * 2014-08-11 2016-03-23 上海和辉光电有限公司 Organic iridium coordination compound and preparation method thereof, light emitting material containing organic iridium coordination compound, and organic electroluminescent device containing organic iridium coordination compound
CN108084231A (en) * 2018-01-31 2018-05-29 安徽工业大学 A kind of material containing iridium complex phosphorescence and preparation and the application in beryllium ion detection
CN108084231B (en) * 2018-01-31 2020-05-12 安徽工业大学 Iridium complex-containing phosphorescent material, preparation and application thereof in beryllium ion detection
CN115160378A (en) * 2021-07-20 2022-10-11 安徽工业大学 Red light organic electrophosphorescent material and preparation method and application thereof
CN115160378B (en) * 2021-07-20 2024-08-20 安徽工业大学 Red-light organic electrophosphorescent material and preparation method and application thereof

Also Published As

Publication number Publication date
CN102180909B (en) 2014-10-22

Similar Documents

Publication Publication Date Title
CN102180909B (en) Iridium complex phosphor material taking phthalazine derivative as ligand and preparation method thereof
CN105679946B (en) Organic photoelectric device and display device
KR100901888B1 (en) Novel organometalic compounds for electroluminescence and organic electroluminescent device using the same
KR101129834B1 (en) Material for phosphorescent light-emitting element and organic electroluminescent element using same
CN103951621B (en) A kind of blue Organic Light Emitting Diode material
CN102812004A (en) Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescent element using same
CN100465168C (en) Oxdiazole derivative and application thereof in electroluminescent material
KR101442982B1 (en) Polycyclic compound and organic electronic device comprising the same
CN102548968A (en) Aromatic heterocyclic derivative and organic electroluminescent element using the same
CN103221407A (en) Oxygen-containing fused ring derivative and organic electroluminescent element comprising same
KR20110086043A (en) Host material for light-emitting diodes
CN102503986A (en) Phosphorescence iridium complex, preparation method and organic electroluminescent device
TWI709250B (en) Organic electroluminescent compounds and organic electroluminescent device comprising the same
Chen et al. Carbazole and benzimidazole/oxadiazole hybrids as bipolar host materials for sky blue, green, and red PhOLEDs
CN103833790B (en) A series of Phosphorescent OLED material
KR101252603B1 (en) Deep-Blue Phosphorescent Iridium(III) Complexes Utilizing N-Methylimidazolyltriazoles
CN108349923A (en) Novel heterocyclic compounds and organic illuminating element including this
KR101986261B1 (en) Compound FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE
CN114573639A (en) Platinum complexes of carbazole-containing ONCN tetradentate ligands
CN105646480A (en) Phenanthroline-bsaed compound and use thereof
Yoon et al. Solution-processed white organic light-emitting diodes with blue fluorescent and orange-red thermally activated delayed fluorescent dendritic luminogens
Zhang et al. Solution-processable orange-red thermally activated delayed fluorescence emitters with 3, 6-disubstituted carbazole for highly efficient OLEDs with low efficiency roll-off
CN102226083A (en) Iridium complex phosphorescent materials with wavelengths from infrared to near-infrared range and preparation method thereof
Girase et al. New deep blue fluorophores based on benzo [d] thiazole group as acceptor core: Theoretical, synthesis, photophysical and electroluminescent investigation
Yang et al. Deep-red thermally activated delayed fluorescence emitters based on a phenanthroline-containing planar acceptor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20110914

Assignee: Jiangsu Nanyou IOT Technology Park Ltd.

Assignor: Nanjing Post & Telecommunication Univ.

Contract record no.: 2016320000208

Denomination of invention: Iridium complex phosphor material taking phthalazine derivative as ligand and preparation method thereof

Granted publication date: 20141022

License type: Common License

Record date: 20161110

LICC Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model
EC01 Cancellation of recordation of patent licensing contract

Assignee: Jiangsu Nanyou IOT Technology Park Ltd.

Assignor: Nanjing Post & Telecommunication Univ.

Contract record no.: 2016320000208

Date of cancellation: 20180116

EC01 Cancellation of recordation of patent licensing contract
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141022

Termination date: 20180318

CF01 Termination of patent right due to non-payment of annual fee